V9I (p.Val9Ile) variant of APOL1 (Apolipoprotein L1)
V9I (p.Val9Ile) in APOL1 (Apolipoprotein L1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.05 / 1. The record also includes population frequency data and structural context.
V9I (p.Val9Ile) variant details
- p.Val9Ile
- rs1028842274
- NCI-TCGA Cosmic COSV5986
- cosmic curated COSV59869
- TOPMed rs1028842274
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.0484
- REVEL 0.05
- CADD 0.07
- PolyPhen-2 0.00
- SIFT 0.15
- UniProt: Variant assessed as somatic; moderate impact.
- Most common in the Non-Finnish European population (allele frequency 1.3e-05)
- Structural context available